Clinical Trial Update: Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures [Phase 3]

View source ↗

Summary

An open-label Phase 3 study evaluated the safety and tolerability of intravenous lacosamide in Japanese adults with partial-onset seizures; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Vimpat (lacosamide)

Snippet

Sponsor: UCB Japan Co. Ltd. | Conditions: Epilepsy, Partial-onset Seizures | Phase 3 | Status: COMPLETED | Results posted: 2015-12-04